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People living with HIV/AIDS experience many losses, one of which 
may be loss of sexual expression. Sexuality has a broader meaning 
than mere sexual intercourse; it encompasses intimacy and impacts 
on psychosocial and spiritual realms. Despite the broader meaning of 
sexuality and that HIV is mainly a sexually transmitted disease; 
carers generally avoid real issues of sexuality. This study explored 
issues of sexuality in people living with AIDS who are given an 
optimistic outlook to life by the availability of HAART. 
 
Methods 
This is a descriptive quantitative study. The respondents were 
purposively sampled from the 850 patients attending the ARV clinic at 
Embhuleni Hospital. Anonymity was assured. The questionnaire was 
available in English as well as two local languages i.e. Zulu and 
SiSwati. The data obtained was entered in Excel. Statistical analysis 




102 questionnaires were completed. There was a significant 
difference between the responses before and after HAART for 
questions on sexual desire, sexual performance, sexual enjoyment 











There was a statistically significant difference between the number of 
partners before and after initiation of HAART.  
 
Although 98/102 (96%) of respondents rated condom use as very 
important, 11/102 (10.78%) of respondents never use condoms 
during sex, and 21/102 (20.58%) indicated that they have had 
unprotected sex in the past 6 months. The most common reasons for 
unprotected sex were that of the partner refusing to use condoms 
(14.7%) followed by that of a desire for pregnancy (7.84%) and 
condom unavailability (6.86%).  
 
18/102 (17.64%) of respondents said it was very important for them 
to have a child and 20/102 (19.6%) were planning to have a child in 
the future. 26/102 (25.29%) of respondents had not disclosed their 
HIV status to their partners. 97/102 (95%) of respondents indicated 
that it is very important to them that health workers discuss their 
sexual needs with them. 
 
Conclusion 
Sexuality in HIV is complex, with participants reporting better sexual 
experience before HAART and a significant number still planning to 
have children. Health workers need to be aware of the complexities 
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Sexuality: The constitution of an individual in relation to sexual 
attitudes and behaviour1. As it involves attitudes and behaviour it 
is governed by spiritual, psychosocial and physical elements. 
 
HIV: Human Immunodeficiency Virus, of which there is type 1 
and type 2. 
 
AIDS: Acquired Immune Deficiency Syndrome. The disease 
caused by HIV by compromising the body’s defence mechanism 
from disease. 
 
HIV/AIDS: Used to denote either the pre-clinical stage and or 
the clinically manifested stage of a compromised immune system 
of an individual. 
 
ARV: Anti-Retro-Virus/Viral. An agent that impacts negatively on 
the multiplication of Retro-Viruses specifically used for retro-
viruses that cause AIDS in this study. 
 
ARVs: A plural denoting more than one agent of ARV sometimes 
used interchangeably with HAART. See below. 
 
HAART: Highly Active Antiretroviral Therapy. Used to denote the 
use of at least three different antiretroviral drugs2. 
 
CD4 Count: A measurement of a sub-type of T-lymphocytes in 
blood used in staging of HIV/AIDS and or assessing response to 
HAART. 
 
Viral Load: A measurement which correlates  to the amount of 
virus in the blood commonly used together with CD4 Count in 
monitoring HIV/AIDS. 
 












     Introduction 
 
Palliative care seeks to address the physical, psychosocial and spiritual well-being 
of the patient who has an incurable disease.The WHO defines palliative care for 
adults as an approach that improves the quality of life of patients and their 
families facing problems associated with life-threatening illness, through the 
prevention and relief of suffering, the early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial 
and spiritual3. The HIV/AIDS epidemic and the availability of HAART has added a 
new dimension in palliative care which initially was provided more for cancer 
patients but today we have more AIDS patient with even more years of mostly 
normal life. The WHO further expands the definition to include the following 
points among others3. Palliative care: 
 Is applicable early in the course of illness, in conjunction with other 
therapies that are implemented to prolong life, such as chemotherapy or 
radiation therapy, (note the conspicuous absence of HAART) and includes 
those investigations needed to better understand and manage distressing 
clinical complications; 
 Provides relief from pain and other distressing symptoms; 
 Intergrates the psychological and spiritual aspects of patient care; 
 Will enhance the quality of life, and will positively influence the course of 
illness. 
 Loss of sexual expression is recognized as one of the losses, which are real or 
perceived by people living with HIV/AIDS. Sexuality has a broader meaning than 
mere sexual intercourse; it encompasses intimacy and impacts on psychosocial 
and spiritual realms. Despite the broader meaning of sexuality and that HIV is 
mainly a sexually transmitted disease; carers generally avoid real issues of 











sex rather than giving space and receptiveness to patients living with HIV/AIDS 
in terms of their sexuality and reproductive rights5. 
 
It is beginning to dawn on carers that reducing issues of sexuality to merely 
condom use or non-condom use as far as HIV/AIDS is concerned may deprive us 
of the broader understanding and hence better communication with patients and 
above all, deprive patients of the total care we strive to deliver physically, 
psychologically and spiritually. 
 
More research on sexuality pertaining to HIV/AIDS is needed in South Africa as 
we grapple with the apparent resistance to changes in sexual behaviour. The 
spread of HIV in our population is mainly related to heterosexual relationships, 
not only among those who have the virus and have not yet progressed to AIDS, 
but also from those who have AIDS but can now live longer because of HAART. 
The question of re-infection and transmission of resistant strains of the HIV 
becomes a concern. 
 
This study attempts to explore some issues of sexuality that may be at play in 
people living with AIDS who are given hope by HAART. Knowing about these 
issues will not only enrich us as carers in offering total care to these patients, but 





















Research articles and paper publications from 1995 to 2008 were searched for 
using the Pubmed, Googlescholar, Biblioline AIDS search and African Healthline 
databases. The search keywords used were “HIV and Sexuality” and “HAART and 
Sexuality”. References from relevant articles led to further articles being found. 
 
Research in sexuality presents unique challenges both to the researcher and 
participant in that sexuality has a lot to do with life history and experience, which 
presents complexities in data collection6. Whyte and Samis contrasted the 
conventional non-democratic nature of researcher-participant relationship with a 
non-structural conversational interview and found that the latter appears to yield 
more rich information, though it is time consuming and presents analytical 
challenges6. Studies cited here relied mainly on structured non-narrative data 
collection. 
 
It is worth noting that earlier studies on sexuality in people living with HIV/AIDS 
were done abroad and among men who have sex with men (MSM). There are 
also more studies abroad covering the Highly Active Antiretroviral Therapy 
(HAART) era than there are in Africa. The reason for the above, needless to say, 
is due to the fact that HIV is mainly heterosexually transmitted in sub-Saharan 
Africa and that HAART has only recently been available in South Africa in 
particular. Research in sexuality relating to HIV/AIDS is needed in South Africa as 
we need to fully understand the apparent resistance to change in sexual 
behavior if we are to impact on the rising number of new cases in parts of the 
country.  
 
The importance of addressing sexuality issues therefore stems from an 











treatment of AIDS7. Studies done in foreign countries may assist us as South 
Africans but their findings may not necessarily apply, South Africa being a 
culturally diverse society and a nation of dual economy. Even with the research 
cited in literature, sometimes the findings are contrary to expectation as 
compared to previous studies on the same research question. 
 
Presented here and briefly discussed are some of the themes in the literature 
regarding sexuality in people living with HIV/AIDS. 
 
Some studies cover more than one theme in that they have more than one 
research question, which may not be inferred from the title of the study. Most 
studies will cover the theme of risky behavior, though this has been cited as a 
deficiency in sexuality studies regarding HIV/AIDS i.e. the apparent 
preoccupation with protected sex. I must add that it is not a question of either/or 
but a caution not to reduce human sexuality to condom or non-condom use5. I 
have classified the research into three themes. Risky behavior is covered by most 
even though it may not be apparent from the research title. 
Theme 1: Effect of HIV on sexuality5,7,8,9 
 
1.1 In women living with HIV/AIDS it was found that:8 
 the majority continue to be sexually active after testing positive 
 sexual function does not change with disease progression 
 few women reported that HIV itself caused worsening of sexual function 
 there was a higher level of sexual function associated with better mental 
health, better quality of life and those who never used intravenous drugs. 
 
1.2 Some women, in particular those with regular new partners since learning 












Theme 2: Effect of HAART on sexuality10,11,12,13,14,15 
 
2.1 HAART was found to decrease libido and lead to an increase in erectile 
dysfunction among MSM and there was an associated increase in 
serum estradiol10. 
 
2.2 Another study found no adverse effect on sexuality among HIV-
positive adults on HAART11. 
 
2.3 A study on HIV-positive women on HAART found that12: 
 They had lowered libido, lowered enjoyment and reduced intimacy. 
 They had barriers to forming relationships due to fears of disclosure 
and fears of infecting partners. 
 They had coping strategies, which involved relationship avoidance, 
having casual partners to avoid disclosure. 
 They had personal dislike for condoms, lack of control, and lack of 
suitable alternatives as far as safe sex was concerned. 
 
2.4 A study among women comparing pre-HAART and after HAART 
became widely available, found that in both eras women frequently 
discussed decreased sexual activity, loss of sexual interest and 
diminished sense of sexual attractiveness following their HIV 
infection13. Reported reasons for discontinuation of sexual activity or 
diminished interest in sex included the following: 
 
 Anxiety about HIV transmission 
 Loss of freedom and spontaneity during sex 
 Fears of emotional hurt 
 Not wanting the hassle of sexual relationships 











 Diminished sense of sexual attractiveness 
 
There was no difference of types of changes in the women’s sexuality nor 
the reasons offered for these changes pre-HAART and HAART eras. 
 
2.5 HAART availability was reported to have impacted on elective 
pregnancies in Cuba14. In this study 64% of women interviewed 
became pregnant while they were aware of their HIV status or that of 
their partner and almost all became pregnant after HAART became 
widely available in Cuba. It was concluded that introduction of 
effective therapy for HIV by changing the social and clinical course of 
HIV/AIDS and allowing the possibility of having HIV-negative children, 
contributed to decreased HIV/AIDS related fears and stigma hence 
reshaping reproduction.  
 
2.6 A Ugandan study which enrolled adults and provided a comprehensive 
home-based ART program, reported 70% reduction in risky sexual 




Theme 3: Risky Behavior In People Living With HIV/AIDS 
 
Most research on sexuality in HIV/AIDS, whatever its purpose is, tends to focus 
on risky behavior and the practice or the non-practice of protected sex. 
Sometimes, it is felt that this focus is at the expense of other considerations, 
given the fact that human sexuality is a complex issue. It is, however, gradually 
becoming clear that for us to understand risky behavior we have to look at 











sanctions5. Many studies have simply quantified how many people did or did not 
use condoms, only a few have attempted to find out what is behind safe and 
unsafe sexual practices among people in general and those living with HIV/AIDS 
in particular. 
 
3.1 Studies have found that to some extent the same determinants of 
unsafe sexual behavior are operative among HIV-positive people as 
they are among people in general16. 
 A study in Russia showed that 50% of people living with  
 HIV/AIDS engaged in unprotected sex and condoms were 
 not used in 1/3 of the time with discordant partners16. 
 Non-anonymous data collection may underestimate high risk 
behavior4 
 Participants expressed dissatisfaction with healthcare providers   
 in addressing their concerns regarding relationships, sexuality and  
 fertility7,17. 
 
3.2 Factors that have been associated with risky behavior in studies as 
primary research and meta-analytical studies are: 
 Gender 
 Cultural and economic factors 
 Urban living versus Rural living 
 Level of education 
 Knowledge that one is already infected with HIV 
3.2.1 An African study cited vulnerability of women to unsafe sex as being due 
to cultural norms, economic dependency and ignorance about 
reproductive and anatomical factors18. 
3.2.2 A study in Zimbabwe found that19: 
 Women were unaware of risk before diagnosis due to gender 











 Women did not disclose their status to health workers due                        
to perceived prejudices that HIV-positive people should not be 
sexually active or have children. 
 Condom use was considered inappropriate in marriage 
 Younger women wanted to become pregnant 
 Safe abortion was inaccessible. 
 
3.2.3 A study in rural KwaZulu/Natal South Africa found that the historical 
process of cultural and religious integration and the contemporary resurgence of 
traditionalism prevented a healthy discourse about healthy sexuality among 
adolescents20. This appeared to be due to stigmatization of sexual activity 
particularly for teenage women, resulting in ambivalence to love and romance 
versus stigma and secrecy; a setting which impedes the prevention of HIV. 
 
3.2.4 Differences in urban versus rural living were demonstrated in a study 
conducted among HIV-infected patients in urban and rural South Africa21. 
 In this study, findings were: 
 Urban respondents were more likely to have current regular sexual 
partners (75.1% vs 46.0%) 
 Urban respondents more likely to have any current sexual partners 
(75.3% vs 51.2%) 
 Urban respondents more likely to report consistent condom use 
with regular partners (78.4% vs 48.3%) 
 Urban respondents more likely to report consistent condom use 
with casual partners (68.6% vs 48.3%) 
 Predictors for consistent condom use with regular partners include, 
across gender, urban residence and higher education level, for 
women an association with disclosure and younger age, for men, 











 Male and female participants with a casual sexual partner were less 
likely to use condoms consistently with regular partners. 
 Predictors of having a regular sexual partner were urban residence 
and a CD4 count above 200 cells/mm3 as well as (for women) 
higher household income and history of alcohol consumption. 
 
3.2.5 High prevalence of risky behavior among men attending a sexually 
transmitted disease clinic in Durban, South Africa was found to be still as high as 
in a previous study in 1988/1989 comparing almost twenty years in the 
HIV/AIDS epidemic22. In this study among men with genital ulcer disease (GUD): 
 Between 33.3% and 43.9% reported sex since the start of 
symptoms compared to 36% in 1988/1989. 
 34.4% of men with confirmed herpetic genital ulceration had had 
sex since the start of symptoms and 93.3% of these had 
unprotected sex. 
It was suggested that this high risk behavior could be due to disinhibition 
because many were already infected with HIV, a low level of education or 
other unknown factors22. 
 
3.3 Age Factor 
In one study, youth were found to engage in unsafe sex and  
 substance use; more so in the post HAART era than pre-HAART.23 
 
3.4 HAART initiation as a factor 
3.4.1 Women were found to engage in unsafe sex after HAART initiation 
irrespective of therapeutic response24  
3.4.2 Among MSM it was found that any decrease in per contact risk of 
HIV transmission due to HAART appeared to have been 
counterbalanced or overwhelmed by an increase in the number of 











3.4.3 Another study with MSM found that HAART initiation may play a 
minor role in contributing to high risk behavior, instead the HIV-
status of partners (serosorting), safe sex fatigue, and the use of 
poppers (drugs) appeared to be more important in understanding 
the sexual risk behavior of HIV-positive MSM26 This study indicated 
a high level of unprotected sex among MSM particularly with HIV-
negative or unknown serostatus partners. 
3.4.4 A meta-analysis of HAART and sexual risk behaviour27 
demonstrated that HIV-positive patients on HAART did not exhibit 
increased sexual risk behavior even when the viral load was 
undetectable. The study found that the prevalence of unprotected 
sex was elevated among those who believed that having an 
undetectable viral load protects against transmitting HIV or who 
had reduced concerns about unsafe sex given availability of HAART 
whether they were HIV-negative, HIV- positive on HAART, or of 
unknown serostatus. It was concluded instead that people’s beliefs 
about HAART and viral load may promote unprotected sex and 
such behavior was amenable through educative messages27. 
3.4.5 Another study found that use of and adherence to HAART and 
suppression of viral load were associated with decreased 
prevalence of self-reported risky sexual behaviour28. 
3.4.6 A short term increase in unsafe sexual behavior was observed in a 
study in Canada after HAART initiation29. The study reported that 
unprotected sexual behavior rose from 20.4% to 30.1% after 
initiation of HAART. 
3.4.7 A study in Thailand examined risky sexual behavior among men 
and women on HAART and the relationships between CD4 levels 
and unprotected sex30 











 23% who were not sexually active after learning of their 
status started having sex after receiving HAART with a 
twelve week median duration from starting HAART and 
having first sex. 
 56% of patients had sex during the previous six months; of 
these 25.5% had sex with commercial partners and 28.4% 
with non-regular partners. 
 Inconsistent condom use with commercial or non-regular 
partners was higher in females (35.3%-36.8%) and lower in 
males (7.8%-11.1%). 
 Participants with known HIV-negative regular partners were 
0.25 times more likely to have unprotected sex than those 
with known HIV-positive regular partners. 
 No association between CD4 levels and unprotected sex was 
found. 
 
3.4.8 A cross-sectional survey of HIV-infected 18-49 year old women in 
Brazil, South Africa and Uganda looked at current HAART use and 
recent sexual intercourse and secondarily to practicing protected 
sex and contraceptive use among HAART users and non-users31. 
The findings were: 
 65% did not want any (more) children. 
 Women on HAART were just as likely as women not on 
HAART to report recent sexual intercourse. 
 Reporting of recent sexual intercourse was associated with: 
- Higher HAART optimism scores rather than HAART use 
itself. 
- Higher education. 
- Being currently married. 











- Desire for more children. 
- Not having been diagnosed with AIDS. 
 63% of women who reported recent sexual intercourse were 
using condoms and women on HAART were significantly 
more likely to practice protected sex. 
 76% were using contraceptive methods and; again women 
on HAART were more likely to use contraceptives albeit non-
significantly. 
 
3.5 Psychosocial needs as a factor for risky behavior 
 
3.5.1 Desire for parenthood32,33 
 
3.5.2 Social validation search34 
A study in Brazil among heterosexual men, heterosexual women 
and MSM found that social validation or acceptance appeared to be 
the main issue rather than availability of HAART. This was found to 
be the psychosocial determinant of unsafe sex and was due to 
shame, denial and fear of disclosure related to HIV but not limited 
to HIV. 
  
3.5.3 Stress caused by disclosure35   
 
3.5.4 A study of sexuality among HIV-positive women since HAART showed 
a high prevalence of sexual difficulties including infrequent sex, 
avoidance, non-communication and dysfunction12. Enjoyment was 
found to be associated with reduced sexual frequency and sexual 













3.5.5 Societal attitudes impacting on stigmatization of sexuality in people 
living with HIV/AIDS. Community attitudes towards sexual activity and 
childbearing were examined in a South African study.36 
 
This study found that: 
 43% of women interviewed thought that people living with 
HIV/AIDS should remain sexually active if they choose to. 
 Only 13% thought that people living with HIV/AIDS should 
have children if they wished. 
 Negative attitudes towards both sexuality and childbearing 
were persistently associated with not knowing someone 
infected with HIV. 
 
In summary, published research has focused on the effect of HIV on sexuality, 
the effect of HAART on sexuality as well as risky behavior in people living with 
HIV/AIDS. Most of the research has been conducted in developed countries. Not 

































The outlook for people living with HIV/AIDS in South Africa has changed since 
the introduction of HAART in public clinics. This study attempts to look at the 
effect of this optimism on sexuality by asking specific questions to participants 
covering areas pertaining to libido, safe sex, reproductive concerns, beliefs and 
attitudes. 
The objectives therefore are: 
 To compare libido, sexual performance, sexual enjoyment 
and frequency among participants before and after HAART. 
 To describe safer sex practices in this sample. 
 To assess the depth of need for participants to discuss 
sexuality with health workers 
 To assess the desire for parenthood in the sample, and 
whether participants are planning to have children. 
 To assess changes in the number partners before and after 
HAART. 
 To assess whether participants have disclosed their status to 
their partners. 
 To find out what could be the most common reason for 











 To assess whether participants believed that taking HAART 
and having an undetectable viral load protects against 
transmitting HIV. 
 To find out whether participants thought some people who 














Type of Study 
This is a descriptive quantitative study. 
 
Study setting 
Embhuleni hospital is a 220 bed hospital in the district of Gert Sibande at Albert 
Luthuli Municipality in Mpumalanga province, South Africa. The hospital serves a 
mostly rural population. The HIV prevalence is estimated at 14.1%. 
 
Sampling 
Eligible participants were selected by the clinic staff as they presented for their 
scheduled or unscheduled visit, and were entered into a potential respondents’ 
list. One hundred and two questionnaires were competed. This size of sample 
was based on the fact that, for proportions near a 50 to 50 split (50%), a large 
sample was required for precision as compared to proportions at extremes e.g. 
10% to 90% split.37 
 
The study in Russia cited in the literature review showed that 50% of people 
living with HIV/AIDS engaged in unprotected sex and condoms were not used 
1/3 of the time16. A larger sample would even have been better but it was 
beyond the means of this study in terms of the number of patients in the clinic, 
time and resources of the investigator.  
 
The respondents were purposively sampled from the 850 patients attending the 
ARV clinic at Embhuleni Hospital. It was established that the clinic operates twice 











the clients have been on HAART for longer than three years, as they have been 
transferred from other ARV clinics.   
 
Inclusion Criteria 
All patients at Embhuleni Hospital over 18 years who were on HAART for at least 
three months were eligible to participate in the study.  
 
Exclusion Criteria 
Patients who were not yet on HAART or on HAART for less than three months 
were excluded. Because of the stigma associated with homosexuality, especially 
in rural areas, participants were not asked about their sexual orientation and 
participants who could be homosexual were not excluded from the study. 
 
Data Collection Tool 
 
The items in the questionnaire were generated from the themes identified in the 
literature. A structured questionnaire, Likert type, was administered to 
respondents. The questionnaire was in English and has been translated into two 
local languages i.e. Zulu and SiSwati. The questionnaire in all three languages 
was piloted among student nurses to ensure validity, reliability and, in the case 
of the Zulu and SiSwati translations, also to test for appropriateness of language. 
No changes were deemed necessary based on the pilot study. Above all this, an 
expert in these languages and in the Nguni cultures has been consulted (see 
under Ethical Considerations below for details).  
 
Volunteer student nurses, suitably trained, administered the questionnaire. These 
student nurses did not form part of the clinic staff, but were in full time block at 
the Clinical Teaching Department under Mrs. A.N. Mkhabela (Principal Tutor). For 











the assistants were called in. The principal tutor was familiar with all three 
questionnaire languages, having assisted in, particularly, the Zulu translation.  
 
The questionnaire was self-administered or partially or completely assisted, 
depending on the need of the respondent in terms of their literacy, 




The data obtained was entered in Excel. Statistical analysis included frequency 
tables, summary statistics and 95% confidence intervals. There was no 
expressed hypothesis or null hypothesis. This was a descriptive study looking for 
a pattern of feelings, thoughts, beliefs and actions. The conclusiveness of results 
using this instrument is not our primary concern as a negative or positive answer 
would be equally significant as much as a neutr l one. The objective of the study 
is to explore issues of sexuality. A single person’s experience, however unique or 
isolated, may provide a point of departure to innovative breakthroughs. 
Statistical significance or insignificance is not necessarily a requirement for 
clinical importance of a result.36  
4.2 Ethical considerations 
 
This study was voluntary and participants were fully informed and had consented 
as per the attached patient information sheet (Appendix 2) and consent form 
(Appendix 3). Anonymity was assured by assigning a number to each 
questionnaire self-picked by the participant from a bag of numbered cards, 
simulating what many would have seen in popular SABC TV games shows. 
 
The questionnaire was in English (Appendix 1), Zulu (Appendix 7) and SiSwati 
(Appendix 10), which are the languages mostly spoken by participants and clinic 











sensitivity to the culturally preferred terminology particularly in issues of 
sexuality as direct translation may be deemed vulgar and/or disrespectful. The 
principal investigator is Swati, married to a Zulu and is in touch with the Nguni 
cultures. Further consultation had been sought from Mr Moses N. Mkhabela, a 
locally renowned linguist who has vast knowledge in Zulu and SiSwati (see 
Appendix 4). 
 
Ethics approval for the study was obtained from the Research Ethics Committee 
at UCT (ref 097/2007), see Appendix 5. Permission to access respondents had 
been given by the Department of Health in Mpumalanga, Hospital services, under 
Dr K. Michaels (Appendix 6).  
 
The clinic operates twice a week. As stated above on methods, diversion of 
clinical staff from their duties was minimised by the use of student nurses 
suitably trained to interface with the respondents, mainly those who, for literacy 
reasons found it difficult to read any of the documents i.e. the information sheet, 
the consent form and the questionnaire. Tentative talk to the clinical staff before 
the study suggested very low literacy levels in vernacular languages i.e. SiSwati 
and Zulu. Privacy was assured by conducting individual interviews in cubicles. 
 
Participants were warned about the intrusiveness of the questions in the 
information sheet. As discussed in the literature review, these questions have 
been asked before. There is no report of any undue emotional upset or harm on 
the participants. However, should these questions have provided any adverse 
emotions, participants were asked to contact the principal investigator who 



















5.1 Demographic data 
 
No one refused to participate in the study. There was a 100% response rate. 
102 questionnaires were filled in.  
Ages ranged from 20yrs to 65yrs with a mean of 37.37 years and a median of 
36yrs. 
There were 76 females (74.51%) and 26 males (25.49%) (Figure 1). 
31.37% were married, 57.84% were single staying alone or with relatives, 
9.90% were cohabiting and 0.98% were divorced. 
25.49% had no partners. 70% had one partner and 5.88% had more than                
one partner as reported on demographic data. 
 














The number of children ranged from 0 to 9 with a mean of 2.67 and a median of 












The median of educational standard was standard 8 with a range of no education 
(0) to a higher education diploma (Table 2). 
 
15.69% (16) were formally employed, 10.78% (11) informally employed and 
71.57% (73) were unemployed (Figure 2). 
 
The median duration of antiretroviral treatment was 12 months with a maximum 
duration of 94 months, and a minimum of 3 months. 
 
Table 1: number of children 
Children Frequency Percent 
0 11 11.78 
1 24 23.53 
2 22 21.57 
3 18 17.65 
4 8 7.84 
5 8 7.64 
6 4 3.92 
7 5 4.90 
8 1 0.98 
9 1 0.98 
Total 102 100% 
 
 
Table 2: Educational standard 
Standard Frequency Percent 
0 8 7.84 
1 4 3.92 
2 1 0.98 
3 4 3.92 
4 4 3.92 
5 9 8.82 
6 14 13.73 
7 5 4.90 
8 7 6.68 
9 15 14.71 
10 29 28.43 
Diploma 2 1.96 





























5.2 Sexual desire, performance, enjoyment and satisfaction 
with frequency of intercourse 
 
The results of the Likert type questions on sexual desire, sexual performance, 
sexual enjoyment and satisfaction with frequency of intercourse were very 
similar. A composite score was created for these questions with the higher score 
indicating a more positive response. 
 
The questions for pre-HAART were: 
 How good was your sexual desire (libido) before you started antiretroviral 
treatment? 
 How good was your sexual performance before you started antiretroviral 
treatment? 
 How good was your sexual enjoyment before you started antiretroviral 
treatment?  
 Were you satisfied with your frequency of sexual intercourse before you 
started your ARV treatment? 
 











  How good is your sexual desire (libido) now that you are on antiretroviral 
treatment? 
 How good is your sexual performance now that you have started 
antiretroviral treatment? 
 How good is your sexual enjoyment now that you are on antiretroviral 
treatment? 
 Are you satisfied with your frequency of sexual intercourse now that you 
are on ARV treatment? 
 
There was a significant difference between the responses before and after 
HAART. The paired t-test was applied to determine the difference in score before 
and after HAART, and a significant difference was found, with a better sexual 
experience before HAART (p=0.0165) ref to table 3. 
 





































5.3 Number of sexual partners 
 
There was a statistically significant difference between the number of partners 
before and after initiation of HAART. The number of respondents who had more 
than one partner before HAART was 39 (38.24%) and on HAART 11 (10.78%). It 
is interesting to note the difference of the response to “more than one partner” 
on completing the demographic data which was the first thing to do on the 
questionnaire, with a score of only 5.88%, against 38.24% on virtually the same 
question coming later in the questionnaire. This possibly demonstrates a more 
relaxed state of mind suggesting a possible under-reporting at first. 
 
Table 4: Number of partners before HAART  

































































































5.4 Importance of using condoms 
 
On answering the question how often they use condoms during sex, 11 
(10.78%) indicated never, 80 (78.43%) indicated always and 11 (10.78%) said 
sometimes. 
 
In response to the question whether they have had unprotected sex in the past 6 
months 21 (20.58%) said yes, 81 (79.4%) said no; which correlates with the 
number that said they always use condoms. Regarding the importance of using 


















N = 102 
Percentage 
 

























5.5 Reasons for engaging in unprotected sex (Table 7) 
 
The responses to the question, “If you were to engage in unprotected sex, what would 
be the most common reason”, are listed in table 7 below.  
Nine (9) respondents did not provide any reason on the self administered, non-assisted 
filling of the questionnaire. 
 








Would dare not 
Not for any reason 
Never dare, will not fall in love again 
It will not happen, I am now a Christian 
Never did 
Not doing 
Dare not-fear of falling pregnant 
 -fear of disease progression 



















Partner refusing to use condom/sometimes 
Partner forces 







Only if being raped 9 8.82% 
Desire for pregnancy 8 7.84% 
Condom availability 7 6.86% 











Fear of disclosure 
If your status was not known by the other 
Will not have sex again husband died 
If viral load is undetectable 
Condom tear 
Fear of condom bursting harming partner 
Dissatisfaction if using condom 
Not feeling good if using condom 
Being overwhelmed with desire 

























The above results can be grouped in two categories, namely those who would 
not engage in unprotected sex, all things being equal, and those who consciously 
decide not to use a condom (Table 8). The 9 (8.82%) respondents who gave no 
answer to the question were excluded from either category. 
 
Table 8: Classification of reasons for engaging in unprotected sex 
 
 
1. Would not engage in unprotected sex all being equal N=69 
 
Percentage  
1.1 Partner refusing 
1.2 Being raped 
1.3 Torn condom 






2. Conscious deciders not to use condom N=24  
2.1 Desire for preg ancy 







5.6 Importance of discussing of sexual needs with 
healthcare workers 
 
97(95%) of respondents indicated that it is very important to them that health 











5.7 Plans to have children 
 
In response to the question “Now that you are on antiretroviral treatment, how 
important is it to you to have a child” 18 (17.64%) indicated very important. Of 
those who indicated very important, 12 (66.67%) are females. 
 
Table 9: Importance of having a child 
 
















































Table 11: Future plans to have a child 
 
Planning to have a child  




































5.9 Belief about HIV transmission 
 
Responding to the question if participants believed that taking ARV protects 
against transmitting HIV, 41 (40.20%) did not believe it did; 15 (14.70%) were 
unsure and 46 (45.10%) did believe that receiving ARV treatment protects 
against transmission of HIV. 
 
Asked if having an undetectable viral load protects against HIV transmission, 42 
(41.18%) participants did not believe it did, 20 (19.60%) were unsure while 40 
(39.22%) believed that having an undetectable viral load protects against HIV 
transmission. 
 
In response to the question whether participants thought some people who are 
HIV positive deliberately infect others, 56 (54.90%) indicated yes. 25 (24.51%) 





























6.1 Demographic data 
 
The limitation of the study includes the small sample and the overrepresentation 
of females among the participants, (74.51%). This was to be expected since the 
clinic is a small volume clinic and operates only twice a week. The female 
predominance may be partly explained by Ante Natal Care (ANC) pickup of HIV-
positive cases as they attend routine ANC clinics which are not attended by their 
male partners. Many studies show that there are more HIV-positive females than 
males and there is anectodal evidence that males are more likely to have 
multiple partners and that one HIV-positive male would infect many females. The 
female predominance therefore could still be a reflection of the prevalence of 
HIV-infection patterns in the population. Despite the median standard of 
education being standard 8, most participants had to be assisted in filling in the 
questionnaire even in vernacular languages. This might have presented 
perceived non-anonymity of the questionnaire by introducing an element of an 
interviewing process which might have resulted in over-reporting of non-risky 
behavior as was found in the Swiss cohort study4. 
 
6.2 Sexual Experience 
 
The significant difference in sexual experience with pre-HAART being better, 
suggests adverse effects of HAART on sexuality among participants. This would 
agree with findings in studies among MSM10 and women on HAART11 which 
reported negative sexual experiences. Other studies report either no adverse 












It is difficult to interpret the results on HAART as some studies report effects of 
HIV itself on sexuality with negative sexual experiences reported among HIV-
positive MSM5 and among people with HIV7. Other psychosocial factors were 
reported to be at play in contributing to negative sexual experiences among HIV-
positive people in general7,8,9 as well as people on HAART12,13,30. These 
psychosocial determinants were reportedly similar both pre-HAART and post-
HAART. Moreover the analysis becomes even more difficult since “before HAART” 
in our questionnaire could mean before the diagnosis of HIV itself spanning the 
time through diagnosis right up to before HAART. After HAART on the other 
hand could include a period when the participants were very sick; seeing the cut 
off CD4 count for initiating treatment among participants is 200 vs 350 in 
developed countries. The median time for resuming sexual intercourse was 
reported to be twelve weeks after HAART initiation in the Thailand study30. 
 
6.3 Number of sexual partners 
 
The statistically significant drop in number of sexual partners on HAART from 
38.24% with more than one partner before HAART, to 10.78% after HAART is 
encouraging. It is worth noting that some of those who requested assistance in 
answering this question did not consider a casual sexual encounter as a 
“partner”. This could mean a once-off sexual experience with someone would not 
be reported as a “partnership” by some participants. On the other hand, how 
many sexual encounters would one describe as casual or regular? It means 
having “one partner” could mean having one regular partner and at least one 
casual partner. This is important since studies show that fears of disclosure could 
lead to casual sexual encounters12,30 as, for example, suggested by the study in 
Thailand in which 28.4% of those who started having sexual intercourse after 
HAART initiation had sex with non-regular partners and 25.5% had sex with 











the number of “partners” but increase the number of episodes of unprotected 
sex due to engagement in unprotected sex with casual partners. 
 
6.4 Importance of using condoms 
 
The importance of using condoms in general scored 96% among participants. 
There was a drop in importance of 6% in using condoms with a HIV-positive 
partner and almost similar drop (5%) if both partners are on HAART. Importance 
of condom use if partner is HIV-negative remained the same as the general 
score of 96%. It appears as though the importance of using condoms in all four 
instances does not translate to actual condom use; as suggested by 78.3% of 
participants who said they always use condoms and 79.4% who reported that 
they have not had unprotected sex in the past six months. There is a difference 
of up to 17.57% (96% minus 78.43%) or 16.6% (96% minus 79.4%). 
 
The above results suggest that if both partners are on HAART or one partner is 
on HAART and the other HIV-positive, they would be more likely not to use a 
condom, on the other hand if one partner is on HAART and the other is HIV-
negative, they would be more likely to use a condom. This result would be 
contrary to that of the Thailand study which reported a 0.25% more likelihood of 
engaging in unprotected sex if one partner was HIV-negative than if HIV-
positive30. 
 
Conceding the participants in this study are rural dwellers; compared to the 
study in urban rural South Africa21; consistent condom use among participants 
(78.43%) is higher than the reported 48.3% for rural dwellers. In fact it is more 
comparable to either the 78.4% for urban with regular partners or the 68.6% for 












Assuming that this study was perceived to be anonymous by participants, the 
results for consistent condom use is comparable but higher that the 73% 
reported among HIV-discordant heterosexuals4. The result is however lower than 
the 88% consistent condom use obtained by interview in the Swiss HIV cohort 
study which was contrasted with the 73% result4. The higher score in the Swiss 
study was interpreted to be due to over-reporting of consistent condom use with 
interviews than with anonymous data collection. 
 
A Russian study reported that 50% of people living with HIV/AIDS engaged in 
unprotected sex and condoms were not used in 33.33% of the time with 
discordant partners16, while the Brazilian, South African and Ugandan cross-
sectional survey reported that 63% of women who reported resent sexual 
intercourse were using condoms31. Compared to above studies, participants in 
this study reported a (significantly) higher condom usage (78.3%). 
 
6.5 The most common reason to engage in 
unprotected sex 
 
The most common reason for engaging in unprotected sex is that of the partner 
refusing to use a condom (14.7%). This reason came exclusively from females. 
The next reason for engaging in unprotected sex was that of a desire to fall 
pregnant (7.84%), followed by that of condom unavailability (6.86%). 
 
Those who would not engage in unprotected sex all being equal as depicted in 
table six, scored 67.64% which is lower than the percentage of participants who 
said they always use condoms (78.43%). 
 
If the reasons for engaging in unprotected sex; “only if being raped” and “torn 











that these are the likely ones to have reported consistent condom use we fall far 
too short of 78.43% who actually reported consistent condom use. This could 
only mean there are those whom we have classified as “conscious deciders not 
to use condom”, (table 6) who nevertheless reported consistent condom use. 
 
6.6 Importance of discussing sexual needs with 
healthcare workers 
 
This study shows that 95% of the participants thought that it was very important 
that healthcare workers discussed their sexual needs. Our study did not look at 
dissatisfaction directly. It was reported in a study that 50% of participants felt 
that healthcare providers did not sufficiently address their concerns regarding 
relationships, sexuality and fertility intentions4. Participants in other studies have 
expressed dissatisfaction with healthcare providers in addressing sexuality 
matters7,17. Further importance of discussing sexuality especially among patients 
on HAART of childbearing age is supported by the Cuban study which reported 
that 64% of women who fell pregnant were aware of their HIV status or that of 
their partner14. 
 
6.7 Plans to have children 
 
68.62% of respondents reported it was not important to have children. This is 
comparable with the 65% among 18yrs-45yrs who did not want to have children 
in the Brazilian, South African and Ugandan cross-sectional survey31. 65% of 
females and 35% of males were planning to have a child in future. For females, 
the result is much higher than the 45% of HIV-positive females who expressed 
desire for children in the Swiss study4 and comparable to the 38% which was 
reported for males4. The Zimbabwean study reported that younger females 












There is no correlation between either those who said it was very important for 
them to have a child or those who are planning to have a child in future, and the 
desire to fall pregnant which scored only 7.84% as a reason for engaging in 
unprotected sex. This could mean participants who desire to fall pregnant are 





25.29% of participants had not disclosed their status to their partners and 
73.53% had disclosed. Several studies have commented on fears of disclosure as 
negatively affecting the sexuality of people living with HIV/AIDS. The dilemma in 
terms of disclosure was mentioned as compromising the sexuality of people 
living with HIV7. Disclosure was also cited as a barrier to forming relationships 
leading to casual sexual partners among women on HAART; to avoid having to 
disclose12. Having disclosed your status was reported to be a predictor for 
consistent condom use among women in the study among HIV-infected patients 
in urban and rural South Africa21. Based on the latter study, one would predict 
consistent condom use among participants to be 73.53%. The reported condom 
use was 78.43% in our study which is close enough. Fear of disclosure related to 
HIV was also mentioned as a determinant for unsafe sex34 and disclosure was 
described as stressful35. The above studies however did not examine percentage 
breakdown of disclosure and non-disclosure among participants. 
 
6.9 Belief about HIV transmission 
 
45.10% of participants believed that taking HAART protects against transmission 











against HIV transmission. Meta-analytic studies demonstrated that patients on 
HAART did not exhibit increased sexual risky behavior even when the viral load 
was undetectable, instead people’s belief about HAART and viral load may 
promote unprotected sex27. Various studies which examined the relationship 
between HAART and risky behavior reported inconsistent result perhaps due to 
different belief-systems amongst the groups studied. Women were found to 
engage in unprotected sex irrespective of therapeutic response24. Among MSM 
the number of unsafe sexual episodes increased after HAART initiation25 while 
another study among MSM found that HAART initiation itself may play a minor 
role, ascribing risky behavior to be due to serosorting, safe sex fatigue and drug 
usage26. A Canadian study reported a short-term increase in unsafe sexual 
behavior after HAART initiation from 20.4% to 30.1%29. There was a decrease in 
prevalence of self-reported risky sexual behavior reported in another study28. It 
appears as though the variability of results in the above studies would support 
the finding of meta-analytic studies that beliefs are at play. On that score a 
45.10% belief that HAART protects against HIV transmission and a 39.22% 
belief that having an undetectable viral load protects against HIV transmission 
would be unacceptably high since this can be easily changed by education. 
 
54.90% of participants thought that some people who are HIV-positive 
deliberately infect others. We have found no precedence in research about this 
question, whether there is truth in it or not. This question was conceived of after 
several patients mentioned that they were deliberately infected. Mostly women 
tend to think this. The result viewed with that of “partner refusing to use a  
condom” as the most common reason for engaging in unprotected sex (14.7%) 
suggests stressful relationships which may compromise sexuality further, as 
would the fear of disclosure. There is a need to make female condoms widely 
available and continue the search for microbicides as an alternative to condoms 












6.10 Limitations of the study 
 
In summary, the limitations of the study included the small sample size and 
the under-representation of males. Biases might also have been introduced 
by the narrow definition of the word ‘partner’ as explained above. Having had 
to assist a number of participants in filling in the questionnaire might have 
jeopardized the sense of anonymity of the process by introducing a feeling of 
being interviewed. 
 
















Our objectives to explore issues of sexuality among respondents have largely 
been met. The knowledge gained may contribute to the care of patients with 
HIV/AIDS especially those on HAART, or at least provide a point of departure for 
further research in this field of palliative medicine in developing countries. 
 
Like in other studies, sexual experience appears to be adversely affected by 
HAART.10,11 
 
The determents of risky behavior are important in order to prevent new 
infections, re-infections and the transmission of resistant strains of HIV from 
participants on HAART. The drop in the number of sexual partners after HAART 
initiation is encouraging, although the adverse effects of HAART must be born in 
mind. 
 
Safer sex practices have further been demonstrated among participants with a 
78.43% reported consistent condom use. There was a demonstrated potential of 
condom use of up to 96% if one were to work on the 90%-96% who said it was 
very important to use condoms. The 4%-10% of those who could engage in 
unprotected sex due to either beliefs about HAART, that it was not important to 
use a condom with an HIV-positive partner, that it was not important to use a 
condom with an HIV-negative partner or that it was not important to use a 
condom if the partner was also on HAART; demonstrated an attitude amenable 
by educative messages. Similarly the 45.10% of participants who believed that 











believed an undetectable viral load protects against the transmission of HIV can 
be changed by education. 
 
 The desire to have children must not be underestimated as a potential for 
unsafe sex and also as a dilemma to couples who want to have children but 
nevertheless use condoms consistently. There are also those who would 
otherwise use condoms consistently but are forced into unsafe sex by partner 
refusing to use a condom. 
 
It appears as though disclosure may be used to measure consiste t condom use 
as demonstrated by the close scores of 73.53% and 78.43% for disclosure and 
consistent condom use respectively. This was also demonstrated in the Swiss 
study.4 From this study it seems there is another fear that operates among 
participants; of being deliberately infected by others with HIV as demonstrated 




We would recommend that the study be repeated with a larger sample with 
gender parity and being well resourced to eliminate contact with participants as 
they fill in the questionnaire. Time frames should be well defined in terms of 
before and after HAART and time frames should not include the period when 
participants were very sick. The duration on HAART should possibly be 6 months 
to 12 months not 3 months as suggested by the Thailand study which 
demonstrated the median duration to resumption of sexual activity to be 12 
weeks30. This is recommended since HAART is initiated at a CD4 count of less 
than 200/mm3 according to the South African Department of Health policy and 
actual enrollment occurs at much lower CD4 levels, hence patients take longer to 
feel well. This is supported by the same study cited above which found recent 












We recommend a clear definition of the word “Partner”, “casual” or “regular” 
partner. 
 
We propose the following model about determinants of risky behavior which 




 Egocentric  - for myself 
 Partnercentric  - for my partner 
 Omnicentric  - for the good of all 




 Socio-Economic factors 
These can be viewed as modulating factors to the intrinsic determinants 
-Education 
-Health  (physical or mental) 
-Gender 
-Age 
-Marital status  
-Urban vs rural 
-HAART optimism 
-Desire for parenthood 
-Drugs and Alcohol  etc 
 
Disclosure; which was found to be a predictor of condom use21 and this seems to 












A further look at indirect ways of determining condom use which may be more 
sensitive than self reported condom use especially in interviews is recommended; 
eg. “Disclosure”, “Desire to have child”, “Unprotected sex in past 6 months” and 
“The most common reason to engage in unprotected sex “, should be compared 
with self reported condom use results. 
 
The result about importance of condom use and beliefs about HIV transmission 
would warrant strengthening of education messages. 
 
A recommendation of widespread availability of condoms especially female 
condoms is warranted. Knowledge about alternative reproductive methods as 
well as provision thereof is recommended to cater for those who still want to 
have children. 
 
We recommend that healthcare workers be empowered with sufficient 
knowledge to be able to anticipate and discuss issues of sexuality with 
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Sexuality issues in patients attending ARV clinic at Embhuleni Hospital in 
Mpumalanga. 
 
1. Demographic data 
 
Please fill in information and tick the correct answer where you are given 
options. 
1.1 Age ____ 
 
1.2 Male     Female 
 
1.3 Married   Single   Cohabiting   
 
Other Please specify e.g. living with  kin or non-kin (living 
with relatives or non-relatives)-----------------------------
------------------------------------------------- 
  
 1.4  No partner  One partner  More than one partner 
 
1.5 Number of children ______________ 
 
1.6 Level of education ________________________ 
 
1.7 Employment _____________________________ 
 














On a scale of 0-4 
 
2. How good was your sexual desire (libido) before you started antiretroviral 
treatment? With 0 indicating poor and 4 indicating excellent.  
0 1 2 3 4 
 
 
3. How good is your sexual desire (libido) now that you have started 
antiretroviral treatment? With 0 indicating poor and 4 indicating excellent. 
0 1 2 3 4 
 
 
4. How good was your sexual performance before you started antiretroviral 
treatment? With 0 indicating poor and 4 indicating excellent. 
0 1 2 3 4 
 
 
5. How good is your sexual performance now that you have started antiretroviral 
treatment? With 0 indicating poor and 4 indicating excellent. 
0 1 2 3 4 
 
 
6. How important is it to you to engage in protected sex i.e. use a condom? With 
0 indicating not important and 4 indicating very important. 













7. If you have sex with an HIV-positive partner, how important is it to have 
protected sex i.e. use a condom?  
With 0 indicating not important and 4 indicating very important. 
0 1 2 3 4 
 
 
8. If you have sex with an HIV-negative partner, how important is it to you to 
have protected sex i.e. use a condom?  
With 0 indicating not important and 4 indicating very important. 
0 1 2 3 4 
 
 
9. If both you and your partner are on antiretroviral treatment, how important is 
it to you to have protected sex i.e. use a condom?  
With 0 indicating not important and 4 indicating very important. 
0 1 2 3 4 
 
 
10. Indicate how often you use a condom during sex.  
With 0 indicating never and 4 indicating always. 
0 1 2 3 4 
 
 
11. How good was your sexual enjoyment before you started antiretroviral 
treatment?  
With 0 indicating poor and 4 indicating excellent. 













12. How good is your sexual enjoyment now that you are on antiretroviral 
treatment? 
 With 0 indicating poor and 4 indicating excellent. 





13. How important is it to you that health workers discuss your sexual needs 
with you?  
With 0 indicating not important and 4 indicating very important. 
0 1 2 3 4 
 
 
14. Now that you are on antiretroviral treatment, how important is it to you to 
have a child?  
With 0 indicating not important and 4 indicating very important. 
0 1 2 3 4 
 
 
15. Were you satisfied with your frequency of sexual intercourse before you 
started your antiretroviral treatment?  
With 0 indicating not at all and 4 very much satisfied. 
0 1 2 3 4 
 
 
16. Are you satisfied with your frequency of sexual intercourse now that you are 
on antiretroviral treatment?  











0 1 2 3 4 
 
 
17. Before you started your antiretroviral treatment, your number of sexual 
partners were as follows:  
0 indicating nil/none ;1 indicating one partner;2 indicating two partners;3 
indicating three partners;and 4 indicating four or more 




18. Now that you have started your antiretroviral treatment, your number of 
sexual partners are as follows: 
0 indicating nil/none; 1 indicating one partner; 2 indicating two partners; 3 
indicating three partners and 4 indicating four partners or more. 
0 1 2 3 4 
 
 
19. Have you disclosed your HIV status to your partner or partners?  
Tick appropriate box. 
   Yes    No 
 
20. In the past six moths, have you had unprotected sex. Tick the appropriate 
box. 
   Yes      No 
 















22. Are you planning to have children in the near future? Tick appropriate box. 
   Yes    No                         Unsure 
 
23. Do you believe that receiving antiretroviral treatment protects against 
transmitting HIV? Tick appropriate box. 
   Yes    No                         Unsure 
 
24. Do you believe that having an undetectable viral load protects against 
transmitting HIV? Tick appropriate box. 




25. Do you think some people who are HIV-positive deliberately infect others? 
 




























PATIENT INFORMATION SHEET 
 
Prospective study of issues of sexuality among patients attending 
ARV clinic at Embhuleni Hospital. 
 
Patient Information Sheet 
 
Translations in SiSwati and Zulu 
 
You are attending the ARV clinic and receiving your treatment as per the 
schedule given to you. 
 
The University of Cape Town is training doctors to be able to offer better care to 
people living with HIV/AIDS and other challenging diseases. Such doctors are 
required to do some research in this field. 
 
If you agree to participate, you shall be given a list of questions by the research 
team, which will take 15 minutes to answer. Only a number will be assigned to 
each questionnaire and not your name. Please ask for help, if you need any, in 
answering the questions. These questions are very intimate, as they require 
information about sex and other related issues. Some questions need either yes 
or no answers but most are answered using a scale of 0-4. Please answer 
honestly and truthfully and without fear, as these answers cannot be traced back 
to you. There is no right or wrong answer. Only your true feelings shall make 
this research useful. Your answer may be 0,1,2,3 or 4, just mark the number 












This study, like many others that have been done in other countries, explores 
matters of sexuality that may be challenging people living with HIV/AIDS who 
are taking ARVs. In most cases the same challenges that you faced before 
starting treatment are compared to the present to see how these have changed 
for better or for worse. 
 
No harm or strong emotions have been reported in answering such questions in 
other studies. However, should you feel discomfort, please report this 
immediately. A free consultation shall be arranged.  
 
The result shall be useful in understanding the challenges that people living with 
HIV/AIDS, particularly those on ARVs face so that when health workers discuss 
strategies to prevent the spread of HIV, do so with sensitivity and appreciation of 
your sexual needs and reproductive rights. It may also help to evaluate where 
knowledge of both health workers and patients needs strengthening. 
 
Patients who are on ARVs for at least three months can participate in the study. 
If you can not read or write, a trained assistant shall be assigned to you. These 
assistants are not part of the clinic staff. 
 
The result of the research will be available at the clinic in early 2008. Please 
indicate on the consent form if you would like to receive a copy of the results. 
 
Again, this research is confidential. Do not write your name on the questionnaire. 
The consent form, which identifies you, will be kept in a locked cupboard away 
from the clinic and since the questionnaire has a number only, it cannot be 
assigned to anybody by name. If you choose not to take part in this study or 
decide to withdraw during the questionnaire, you are free to do so and you will 












Please take these phone numbers home with you. If you need further 
clarification please call any of the following. 
Principal Investigator : Dr M.R. Mkhablela  Tel No: 017 883 0655 
 
Assistants (Clinical Teaching Department) 
    1. Ms A.N. Mkhabela Tel No: 017 883 0093 
    2. Ms O.P. Buthelezi  Tel No: 017 883 0093 













































Prospective study of issues of sexuality among patients attending 
ARV clinic at Embhuleni Hospital. 
 
Patient Consent Form 
Translation in SiSwati and Zulu 
 
I, _____________________________________________, have read the patient 
information sheet and have had the research explained to me 
by_____________________________________________. 
 
I understand the information given to me and have been able to ask questions 
about the research. I know that if I decide to withdraw during the time of the 
questionnaire my care and treatment will still be the same. 
 
I would like/would not like to receive results of the research study. 
 
Signed ___________________________ Date__________________________ 
 




















TRANSLATING WITH LANGUAGE 
APPROPRIATENESS 
 
Mr. Moses N Mkhabela is a retired teacher who taught Afrikaans and English. He 
has a BA degree with UNISA majoring in Anthropology and languages. He was 
head of the language Board in the Ka-Ngwane Homeland Government under 
Minister E.J. Mabuza and is experienced in translations, having translated various 
English and Afrikaans text into SiSwati including the English Bible. 
 
His work is acknowledged by Dr Mafika Lubisi, a lecturer at the University of 
Zululand with a doctorate in SiSwati and Prof  P.J. Shongwe attached to the 
Tshwane University of Technology, Nelspruit campus involved in SiSwati 
language. Recently, Mr. Mkhabela has been invited to participate in the launching 
of the SiSwati dictionary, the compilation of which his contribution has been 
invaluable. 
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Enquiries: Nkhum;sen; Mphathele (013) 766 3235 
Or. M.R. Mkhabela 
P.O. Box 789 
Elukwatini 
1192 
10 September 2007 
Application For Research Ethics Approval: Sexuality issues in patients 
attending ARV clinical Embhuleroi Hospital in Mpumalanga 
The Provincial Research and Ethics Committee has approved your research 
proposal in the current format. No Issues of ethical consideration were 
identified. 






















IZINDABA MAYELANA NEZOCANSI EZIGULINI EZIHAMBELA 





1. IMINININGWANE YENANI LABANTU 
 
Uyacelwa ukuba uphendule lemibuzo elandelayo ngokugcwalisa ezikhaleni 
ezifanele, kokunye ukhethe impendulo ovumelana nayo ngokukhombisa 
ngophawu u-X ebhokisini elifanele. 
  
1.1 Iminyaka yobudala bakho……………………………………… 
1.2 Ungowesilisa     Ungowesifazane 
1.3 Ushadile   Awushadile  Ukumasihlalisane    
Okunye 
 Nikeza incazelo yokuthi umuntu ohlala naye uyisihlobo sakho, noma  
wumuntu okuhawukele nje……………………………………………………… 
1.4 Awunamngani oya naye ocansini  
Unomngani oyedwa oya naye ocansini        
Unabangani abeqa koyedwa oya nabo ocansini 
1.5 Inani lezingane zakho……………………………………………….. 























Esikalini sika 0-4 
2. Belingakanani izinga lakho lenkanuko yocansi ngaphambi kokuba uqale 
ukwelaswha ngama-ARV? 
(Lapho kukhona u-0 kukhombisa ukuthi beliphansi kakhulu lapho kukhona u-4 
kukhombisa ukuthi beliphezulu ngokwadlulele) 
0 1 2 3 4 
 
3. Lingakanani izinga lenkanuko yakho yocansi njengoba usuqale ukwelashwa 
ngama-ARV? 
(Lapho kukhona u-0 kukhombisa ukuthi liphansi ngendlela engagculisi kuthi 
lapho kukhona u-4 kukhombise ukugculiseka okwadlulele) 
0 1 2 3 4 
 
4. Ubusebenza kahle kangakanani ususocansini ngaphambi kokuba uqale 
ukwelashwa ngama-ARV? 
(Lapho kukhona u-0 kukhombisa ukuba phansi kakhulu kuthi lapho kukhona 
u-4 kukhombise ukwedlulela) 
0 1 2 3 4 
 
5. Ususebenza kahle kangakanani ocansini njengalokhu usuqale ukwelashwa 
ngama-ARV? 
(Lapho kukhona u-0 kukhombisa ukuba phansi kakhulu kuthi lapho kukhona 
u-4 kukhombise ukwedlulela) 












6. Kubaluleke kangananani kuwe ukuthi uye ocansini uvikelekile, okusho 
ukuthi usebenzise i-khondomu? 
(Lapho kukhona u-0 kukhombisa ukuthi akubalulekile kuthi lapho kukhona u-
4 kukhombise ukuthi kubaluleke kakhulu) 
0 1 2 3 4 
 
7. Uma uya ocansini nomngani onegciwane lengculazi i-HIV, kubaluleke 
kangakanani ukuthi uye ocansini uvikelekile, njengokusebenzisa i-
khondomu? 
(Lapho kukhona u-0 kukhombisa ukuthi akubalulekile kuthi lapho kukhona u-
4 kukhombise ukuthi kubaluleke kakhulu) 
0 1 2 3 4 
 
8. Uma uya ocansini nomngani ongenalo igciwane lengculazi i-HIV, kubaluleke 
kangakanani ukuthi uye ocansini uvikelekile, njengokusebenzisa i-
khondomu? 
(Lapho kukhona u-0 kukhombisa ukuthi akubalulekile kuthi lapho kukhona u-
4 kukhombise ukuthi kubaluleke kakhulu) 
0 1 2 3 4 
 
9. Uma nobabili, wena kanye nomngani wakho wezocansi nelashwa nge-ARV, 












(Lapho kukhona u-0 kukhombisa ukuthi akubalulekile kuthi lapho kukhona u-
4 kukhombise ukuthi kubaluleke kakhulu) 
0 1 2 3 4 
 
10. Uvamise kangakanani ukusebenzisa i-khondomu uma uya ocansini? 
(Lapho kukhona u-0 kukhombisa ukuthi awukaze kuthi lapho kukhona u-4 
kukhombise ukuthi ngaso sonke isikhathi) 
0 1 2 3 4 
 
11. Bewukujabulela kahle kangakanani ukuya ocansini ngaphambi kokuba uqale 
ukwelashwa ngama-ARV? 
(Lapho kukhona u-0 kukhombisa ukuthi bewungakujabuleli kahle kuthi lapho 
kukhona u-4 kukhombise ukuthi bewukujabulela ngokweqile) 
0 1 2 3 4 
 
12. Sewukujabulela kangakanani ukuya ocansini njengoba sewaqala 
ukwelashwa ngama-ARV? 
(Lapho kukhona u-0 kukhombisa ukuthi ukujabulela kancane kuthi lapho 
kukhona u-4 kukhombise ukuthi ukujabulela ngokweqile) 
0 1 2 3 4 
 
13. Kubaluleke kangakanani kuwe ukuthi izisebenzi zezempilo zixoxisane nawe 











(Lapho kukhona u-0 kukhombisa ukuthi akubalulekile kuthi lapho kukhona u-
4 kukhombise ukuthi kubaluleke kakhulu) 
0 1 2 3 4 
 
14. Njengoba sewelashwa ngama-ARV, kubaluleke kangakanani kuwe ukuthola 
ingane? 
(Lapho kukhona u-0 kukhombisa ukuthi akubalulekile kuthi lapho kukhona u-
4 kukhombise ukuthi kubaluleke kakhulu) 
0 1 2 3 4 
 
15. Beweneliseka yini, ngemvamisa yakho yokuya ocansini, ngaphambi kokuba 
uqale ukwelashwa nge-ARV? 
(Lapho kukhona u-0 kukhombisa  ukungeneliseki bese kuthi lapho kukhona u-
4 kukhombise ukuthi beweneliseka ngokweqile) 
0 1 2 3 4 
 
16. Uyaneliseka yini ngemvamisa yakho yokuya ocansini njengoba sewelashwa 
nge-ARV? 
(Lapho kukhona u-0 kukhombisa ukungeneliseki bese kuthi lapho kukhona u-
4 kukhombise ukuthi wenelisekile ngokweqile) 
0 1 2 3 4 
 
17. Ngaphambi kokuthi uqale ukwelashwa ngama-ARV inani labangani bakho 











(Lapho kukhona u-0 kukhombisa ukuthi bebengekho, u-1 akhombise ukuthi 
ubeyedwa nje vo, u-2 akhombise ukuthi bebebabili, u-3 akhombise ukuthi 
bebebathathu, bese kuthi  u-4 akhombise ukuthi bebebane noma 
ngaphezulu) 
0 1 2 3 4 
 
 
18. Njengoba sewuqalile ukwelashwa ngama-ARV, inani labangani bakho 
bezocansi selinjengalokhu okulandelayo: 
(Lapho kukhona u-0 kukhombisa ukuthi awunabo, u-1 akhombise ukuthi 
uyedwa nje vo, u-2 akhombise ukuthi babili, u-3 akhombise ukuthi bathathu, 
bese kuthi  u-4 akhombise ukuthi bane noma ngaphezulu) 
0 1 2 3 4 
 
19. Usivezile yini isimo sakho sengculazi i-HIV, kumngani wakho noma 
kubangani bakho bezocansi? 
Khombisa ngophawu u-X ebhokisini elifanela YEBO         CHA  
 
20. Kulezizinyanga eziyisithupha ezedlule, ubusuke waya yini ocansini 
ungavikelekile?  












21. Uma bewungahle uye ocansini ungakavikeleki, bekungaba yini isizathu 




22. Ingabe upulanela (uhlose) ukuthi ube nezingane yini kulesikhathi esimaduze 
esizayo?  
Khombisa ngophawu u-X ebhokisini elifanela           
Yebo                  Cha                       Angina(li)qiniso 
23. Uyakholelwa yini ekutheni ukwelashwa ngama-ARV kuyavikela ukuthi 
igciwane lengculazi i-HIV ledlulele kwabanye?  
Khombisa ngophawu u-X ebhokisini elifanela                    
Yebo                 Cha                        Angina(li)qiniso 
24. Uyakholelwa yini ekutheni ukuba ne-viral load engabonakali kuyavikela 
ekutheni igciwane lengculazi ledlulele kwabanye?  
Khombisa ngophawu u-X ebhokisini elifanela            
Yebo                 Cha                        Angina(li)qiniso 
25. Ucabanga ukuthi abanye abantu abanegciwane lengculazi i-HIV badlulisela 
kwabanye ngesibomu na?  
Khombisa ngophawu u-X ebhokisini elifanela           



















UKUFUNDA OKUBUKELELEKILE MAYELANA NEZINDABA ZOCANSI 
PHAKATHI KWEZIGULI EZIHAMBELA EMTHOLAMPILO WAMA – A.R.V 
ESIBHEDLELA SASE – EMBHULENI ESIFUNDENI SASE – MPUMALANGA  
 
IPHEPHA LOKWAZISA ISIGULI 
 
Uhambela emtholampilo wama – A.R.V, futhi uthola ukwelashwa ngendlela 
ehambisana naloluhla onikezwe lona. 
 
I – Nyuvesi yase – Cape Town iqeqesha odokotela ukuthi bakwazi ukunakekela 
kangcono abantu abaphila negciwane lengculazi nesandulela sayo i-HIV/AIDS 
kanye nezifo eziyinselelo. Abanye odokotela kufanele benze ucwaningo-thizeni 
kulendima. 
 
Uma uvuma ukuzibandakanya kulolucwaningo, uzonikezwa uhlu lwemibuzo, 
yilabasebenzi abenza lolucwaningo, oluzothatha imizuzwana ethi mayibe yishumi 
nanhlanu. Uzonikezwa inombolo nje kuphela kulolo nalolo luhla lwemibuzo hayi 
igama lakho. Wamukelekile ukucela usizo lapho uludinga khona ekuphenduleni 
lemibuzo. Lemibuzo ijule kakhulu mayelana nezothando, kanti futhi idinga 
imininingwane mayelana nezocansi nezinye nje izinto eziphathelene nalo. Eminye 
imibuzo idinga impendulo ka Yebo noma Cha, kodwa eminingi yawo iphendulwa 
ngesikalo sika 0-4. Uyacelwa ukuba uphendule lemibuzo ngobuqotho 
nangeqiniso, nangaphandle kokwesaba, ngoba lezimpendulo angeke kuphinde 
kutholakale ukuthi ziqhamuke kuwe. Akukho impendulo e-right noma e-











Impendulo yakho kungaba wu-0,1,2,3 noma 4. Wena khetha lenombolo 
eseduzane nalendlela ozizwa ngayo. 
 
Lesifundo, njengezinye ezenziwa kwamanye amazwe, sithungatha imininingwane 
yezocansi engase ibe yinselelo kubantu abaphila ne HIV/AIDS abelashwa ngama 
ARV. Ezikhathini eziningi kuqhathaniswa izinselelo owawubhekene nazo 
ungakaqali ukwelashwa ngama ARV namanje njengoba sewelashwa ngawo, 
ukuze kubonakale ushintsho noma ngabe luhle noma ngabe sekukubi 
ukwedlulela. 
 
Akekho owake walinyazwa yilemibuzo noma okwathinteka kuye imizwa 
kabuhlungu ezifundweni ezinye ezenziwa kodwa uma ungase ungazizwa kahle, 
uyacelwa ukuba ubike lokhu ngokushesha. Amalungiselelo azokwenziwa ukuze 
ubonwe ngudokotela ngaphandle kwezindleko. 
 
Imiphumela yalesifundo izoba usizo ekuqondeni ngenselelo ebhekene nabantu 
abaphila ne HIV/AIDS, ikakhulu labo abakuma ARV. Ngalokho kuzothi lapho 
izisebenzi zasemtholampilo zixoxa ngokuvikela kokubhebhetheka kwe HIV, 
zikwenze ngozwelo nokuqondisisa izidingo zakho zezocansi kanye namalungelo 
enzalo. Lesifundo singahle sibe wusizo futhi ekutholeni ukuthi yikuphi lapho 
ulwazi lwethu siyiziguli noma siyizisebenzi zasemtholampilo ludinga ukuqiniswa. 
 
Izigulane ezikuma ARV izinyanga ezintathu kuye ngaphezulu zingahlanganyela 
kulesifundo. Uma unenkinga yokufunda kumbe ukubhala uzonikezwa umelekeleli 
oqeqeshiwe. Labalekeleli abasiyo ingxenye yabasebenzi balapha emtholampilo. 
 
Imiphumela yocwaningo izotholakala emtholampilo ekuqaleni konyaka 
olandelayo ka-2008.Uyacelwa ukuba ukhombise kulelifomu lemvume yakho, uma 












Kuyagcizelelwa futhi ukuthi lolucwaningo olwesifubu sakho, ungabhali igama 
lakho kuloluhla lwemibuzo. Lefomu yemvume yokho, eyazisa ukuthi wena 
ungubani, lizogcinwa ekhabetheni ekhiywayo elikude nomtholampilo, futhi ngoba 
loluhlamibuzo lunezinombolo nje kuphela angeke liyamaniswe negama lomuntu. 
Uma ukhetha ukungahlanganyeli kulesifundo noma unqume ukuhoxa ngesikhathi 
saloluhla lwemibuzo wamukelekile ukwenza njalo, futhi uzosolokhu uthola 
unakekelo nokwelashwa okufanele. 
 
Thatha lezinombolo zocingo uye nazo ekhaya. Uma udinga ukucaciselwa, 
wamukelekile ukushayela kunoma iyiphi yalezinombolo ezilandelayo: 
 
Umcwaninginhloko:    Dr M.R.Mkhabela Tel No: 017 883 0655 
 
Abalekeleli:        1.Ms A.N.Mkhabela    Tel No: 017 883 0093 
        
        2. Ms O.P.Buthelezi    Tel No: 017 883 0094 
 






























UKUFUNDA OKUBUKELELEKILE MAYELANA NEZINDABA ZOCANSI 
PHAKATHI KWEZIGULI EZIHAMBELA EMTHOLAMPILO WAMA-ARV 
ESIBHEDLELA SASE-EMBHULENI ESIFUNDENI SASE-MPUMALANGA 
 
IFOMU YEMVUME YESIGULI 
Mina…………………………………………………………………..ngilifundile leliphepha 
lokwazisa isiguli, ngabuye ngachazelwa ngalocwaningo 
ngu………………………………………………………………………… 
 
Ngiyaluqonda lolwazi enginikezwe lona, futhi ngikhonile ukubuza imibuzo 
mayelana nalocwaningo. Ngiyazi ukuthi manginquma ukuhoxa ngesikathi 
salohla lwemibuzo, ukunakekelwa kwami kuzosolokhu kufanana. 
 
Ngingathanda/A githandi ukuthola imiphumela yalocwaningo. 
 
Sayina La……………………………..  Usuku………………………………… 




















TINDZABA TETEMACANSI ETIGULANENI LETIHAMBELA 
EMFTOLAMPHILO WEMA–ARV ESIBHEDLELA SASE  EMBHULENI 
ESIFUNDZENI SASE MPUMALANGA  
 
1. Idata yeLinanibanftu 
 
Wena wekunene gcwalisa lolwati lolufunekako, futsi uthike etikhaleni lapho 
kunekukhetsa impendvulo lefanele kuletinye: 
 
1.1. Budzala …………………………………….. 
 
1.2. Dvuna                    Sikati              
 
1.3.  Shadile                          Singili                         Mahlalisana             
 
Lokunye              
 
Sita ucacise e.g. uhlala nesinini sakho kumbe nemuntfu lokuhawukele 
nje…………………………………………………………………. 
 
1.4.  Ngenamnganicansi             Mnganicansi Munye            
 
Mnganicansi kwengca kumunye            
 
1.5. Linanibanfwana: ………………………………. 
1.6. Lizingamfundzo: ………………………………. 
1.7. Umsenti: ………………………………………... 


















Esikalini 0 – 4 
 
2. Kukhanuka licansi bekukahle kangakanani ngembi kwekube ucale kwelashwa 
nge ARV?  
(Lapho 0 akhomba kusho kutsi bekuphansi kutsi 4 akhombe kutsi bekukahle 
kwengcelele) 
 
0 1 2 3 4 
 
3. Kunjani kukhanuka kwakho licansi manje losewucale kwelashwa nge ARV? 
(Lapho 0 akhomba kusho kutsi kuphansi kutsi 4 akhombe kutsi kukahle 
kwengcelele) 
 
0 1 2 3 4 
 
4. Bewusebenta kahle kanganani sewusecansini, ngembi kwekube ucale 
kwelashwa nge ARV?  
(Lapho 0 akhomba kubaphansi kutsi 4 akhombe kuba kahle kwengcelele) 
 
0 1 2 3 4 
 
5. Sewusebenta kahle kanganani ecansini manje losewucale kwelashwa nge 
ARV? 
(Lapho 0 akhomba kubaphansi kutsi 4 akhombe kuba kahle kwengcelele) 
 
0 1 2 3 4 
 
6. Kubaluleke kanganani kuwe kutsi uye ecansini uvikelekile, lokusho kutsi ufake 
ikhondomu? 
(Lapho 0 akhomba kungabaluleki kutsi 4 akhombe kubaluleka kakhulu) 
 



















7. Uma uya ecansini nemngani loneligciwane leHIV, kubaluleke kanganani kuya 
ecansini uvikelekile – njengekusebentisa ikhondomu? 
(Lapho 0 akhomba kungabaluleki kutsi 4 akhombe kubaluleka kakhulu) 
 
0 1 2 3 4 
 
8. Uma uya ecansini nemuntfu longenalo ligciwane leHIV, kubaluleke kanganani 
kuwe kuya ecansini uvikelekile – njengokusebentisa ikhondomu? 
(Lapho 0 akhomba kungabaluleki  kutsi 4 akhombe kubaluleka kakhulu) 
 
0 1 2 3 4 
 
9. Uma nobalili wena nemngani wakho nisekwelashweni ngeARV, kubalulele 
kanganani kuya ecansini nivikelekile – njengekusebentisa ikhondomu? 
(Lapho 0 akhomba kungabaluleki kutsi 4 akhombe kubaluleka kakhulu) 
 
0 1 2 3 4 
 
10. Uvamise kanganani kesebentisa ikhondomu ngesikhatsi uya ecansini? 
(Lapho 0 akhomba kusho kutsi akaze kutsi 4 akhombe sonkhe sikhatsi) 
 
0 1 2 3 4 
 
11. Bewukujabulela kahle kanganani kuya ecansini ngembi kwekutsi ucale 
kwelashwa ngeARV? 
(Lapho 0 akhomba kujabulela lokuphansi kutsi 4 kujabulela kwengcelele) 
 












12.  Sewukujabulela kanganani kuya ecansini nyalo loku sewusekwelashweni 
ngeARV? 






13. Kubaluleke kanganani kuwe kutsi tisebenti teTemphilo ticocisane nawe 
ngetidzingo takho nge tekuya emacansini? 
(Lapho 0 akhomba kungabaluleki kutsi 4 akhombe kubaluleka kakhulu) 
 
0 1 2 3 4 
 
14. Manje-ke losewusekwelashweni ngeARV, kubaluleke kangakanani kuwe 
kutfola umntfwana? 
(Lapho 0 akhomba kungabaluleki kutsi 4 akhombe kubaluleka kakhulu) 
 
0 1 2 3 4 
 
15. Beweneliseka yini ngemvamisa yekuya kwakho emacansini ngembikwekube 
ucale kwelashwa ngeARV? 
(Lapho 0 akhomba hhayi nakancane kutsi 4 akhombe kweneliseka kakhulu 
khulu) 
 
0 1 2 3 4 
 
16. Wenelisekile yini ngemvamisa yakho kuya emacansini manje 
losewusekwelashweni ngeARV? 
(Lapho 0 akhomba hhayi nakancane kutsi 4 akhombe kweneliseka kakhulu 
khulu) 
 
0 1 2 3 4 
 











17. Ngembikwekube ucale kwelashwa kwakho ngeARV linani lebangani bakho 
basecansini belinjengalokulandzelako yini? 
(Lapho 0 akhomba kutsi bekute kutsi, 1-munye, 2-Babili, 3-Batsatfu kutsi 4- 
bane nangetulu) 
 
0 1 2 3 4 
 
 
18. Manje lokusewucale kwelashwa kwakho ngeARV, linani lebangani bakho 
basemacansini linjengalolokulandzelako? 






19. Usivetile yini simo sakho seHIV kumngani wakho / kubangani bakho 
(basecansini) 
Faka X ebhokisini lelifanele    Yebo          Cha         
 
20. Kuletinyanga letisiftupha letengcile, usewaya yini ecansini ungakavikeleki? 
Faka X ebhokisini lelifanele    Yebo          Cha         
 
21. Uma bewungase uye ecansini ungakavikeleki, bekungaba yini sizathu 




22. Utimisele kutsi ube nebantfwana yini kulesikhatsi lesimadvute lesitako? 
Faka X ebhokisini lelifanele                                      
 
   Yebo                Cha                 Angina(li)ciniso 
 
23. Uyakholelwa yini ekutseni kuftola kwelashwa ngeARV kuyakuvikela 
ekwengceseleleni labanye iHIV? 











Faka X ebhokisini lelifanele                             
 
   Yebo                Cha                Angina(li)ciniso 
 
24. Uyakholelwa ekutseni na une-viral load lebhacile (lengabonakali) kungavikela 
kwengcisekela kweHIV kulabanye? 
Faka X ebhokisini lelifanele                       
 
   Yebo                Cha                Angina(li)ciniso      
 
25. Ucabanga kutsi labanye baftu labaneHIV, bengciselela labanye ngesibomu? 
Faka X ebhokisini lelifanele                                
 

































SiSwati Translated Patient Information Sheet 
 
SINETELELO 2: LIPHEPHA LEKWATISA SIGULANE 
(SWATI TRANSLATION) 
 
KUFUNDZA LOKUBUKELELEKILE NGETINDZABA TASEMACANSINI 
EMKHATSINI WETIGULANE LETIHAMBELA EMTFOLAMPILO WE-ARV 
ESIBHEDLELA SASEMBHULENI 
 
Liphepha lekwatisa sigulane 
 
Uhambela emtfolampilo weARV futsi utfola kwelashwa ngalelekuhambisana 
naleshejuli loniketwe yona. 
 
I-Yunivesi yase-Cape Town icecesha bodokodela kutsi bakhone kutsi banikete 
lunakekelo loluncono kubantfu, labaphila neHIV / AIDS kanye netifo letiyiselele. 
Bodokodela labanje kudzingakele kutsi bente luncwaningo tsite kulendzima. 
 
Nangabe uvuma kutibandzakanya kulolucwaningo, utawunikwa luhlu lwemibuto 
ngulethimu leyenta lolucwaningo, lolutawutsatsa emaminithi langu 15. 
Kutawuniketwa inombolo kuphela kulolo nalolo luhlamibuto, hhayi libito lakho. 
Na udzinga noma ngiluphi lusito ekuphendvuleni kwalemibuto sita-ke ulucele. 
Lemibuto ingeyebutsandzani njengoba ifuna lwati ngetasemacansini, kanye 
nalokuphatselene naloko. Leminye imibuto idzinga kulokunye impendvulo ya 
Yebo kumbe Cha, kodwa liningi layo liphendvulwa ngekusebentisa sikalo sa 0 – 
4. Sitake uphendvule ngebucotfo nange liciniso, futsi ngaphandle kwekwesaba 
ngoba letimphendvulo ngeke phindze kutfolakale kutsi tichamuka kuwe. Akukho 
impendvulo – right kumbe – wrong. Luvo lwakho lwangasibili kuphela 
lolutakwenta lolucwaningo lube nelusito. Imphendvulo yakho kungaba ngu 















Imiphumela yalolucwaningo itawutfolakala emtfolamphilo ngekuhamba  nakucala 
umnyaka 2008. Sita ukhombise efomini lemvuma na ungatsandza kutfola ikhophi 
yalemiphumela. 
 
Njengaletinyenti letinye lesetentiwe kulamanye mave, lesifundvo sitfungatsa 
tindzaba tetemacansi lekungase kube tiyinselele kubantfu labaphila ne-HIV/AIDS 
nalabatsatsa ema-ARV. Kulokunyenti, tona leto tinselele lebe ubukene nato 
ngembikwekube ucale kwelashwa, ticatsaniswa naletalesikhatsi lesikuso, kubona 
kutsi letamuva tintjintjele ebunconweni kumbe sekubi kakhulu kunasekucaleni. 
Akukho lokulimatako kumbe kuvelela lokumatima lokubikiwe nakuphendvulwa 
lemibuto kuletinye tifundvo. Kodvwa-ke nakungenteka ungativa kahle, bika 
masinyane. Utakwentelwa malungiselelo okubonana nadokodela ngaphandle 
kwetindleko.  
 
Imiphumela itawuba lusito ekucondzeni letinselele le bantfu labaphila ne-
HIV/AIDS ikakhulu labo bantfu labelashwangema-ARV babhekene nato kute kutsi 
ngesikhatsi tisebenti tetemphilo ticocisane ngetindlelahlasela tekuvikela 
kubhebhetseka kwe-HIV, tente kanjalo ngekuvelela nekucondzisisa tidzingo 
takho tasemacansini kanye netemalungelo akho ekutfola bantfwana. Kungasita 
futsi ekuhluteni lapho lwati lwetisebenti temphilo netigulane tidzinga kuqinisiswa.   
 
Tigulane letikuma-ARV tinyanga letiintsatfu kuyengetulu tingahlanganyela 
kulesifundvo.  
 
Na ungakukhoni kufundza kumbe kubhala utawunika umelekeleli loceceshiwe. 












Ngiyaphindza futsi ngitsi lolucwaningo ngelwesifuba. ungabhali libito lakho 
kuloluhlamibuto. Lefomu yemvume leyatisa kutsi wena ungubani, litawubekwa 
ekhabethini lelikhiyiwe ekudzeni nemtfolampilo, futsi ngobe loluhlamibuto 
lunemombolo nje kuphela ngeke iniketwe nome ngubani ngelibito. Na ukhetsa 
kungahlanganyeli kulesifundvo kumbe uncume kuhoca ngalesikhatsi 




Tsatsa letinombolo telucingo uye nato ekhaya. Na udzinga lokunye 
kukhanyiselwa, sita ushayele kunobe nguyiphi yaletinombolo letiladzelako: 
 
Umcwaninginhlobo  : Dr M.R. Mkhabela  Tel No: 017 883 0655 
Balekeleli    1. Ms A.N. Mkhabela  Tel No: 017 883 0093 
   2. Ms O.P. Buthelezi  Tel No: 017 883 0093  
 





























SiSwati Translated Consent Form 
 
SINETELELO 3: IFOMU YEMVUME YESIGULANE 
(SWATI TRANSLATION) 
 
KUFUNDZA LOKUBUKELELEKILE NGETINDZABA TASEMACANSINI 
EMKHATSINI WETIGULANE LETIHAMBELA EMTFOLAMPILO WEARV 
ESIBHEDLELA SASEMBULENI 
 
Ifomu Yemvume Yesigulane 
 
Mine …………………………………………………. ngilifundzile leliphepha lwekwatisa 
sigulane, ngabuye ngachazelwa ngalolucwaningo  ngu 
………………………………………….. 
 
Ngiyalucondza lolwati lenginiketwe lona, futsi ngikukhonile kubuta imibuto 
mayelana nalolucwaningo. Ngiyati kutsi nangincuma kuhoca ngesikhatsi 
saloluhlamibuto, lunakekelo nekwelashwa kwami kutawusolo kufana. 
 
Ngingatsandza / Ngingete ngatsandza kutfola imiphumela yalolucwaningo. 
 
Isayini ……………………………….  Lusuku ………………………… 
 
Fakazi ……………………………….  Lusuku ………………………… 
 
 
